Provider Reviews

Try Ageless vs RxActivate: Formats, Pricing, Eligibility Compared

Trying to decide between Try Ageless vs RxActivate? Quick verdict: Try Ageless is best if you want transparent starting prices and multiple GLP-1 formats, including needle-free tirzepatide drops from $159/mo. RxActivate is best if you prefer clinician-matched plans but are willing to complete an eligibility flow before seeing price and terms.

View Try Ageless formats and pricing

How the two providers differ at a glance

The comparison centers on format availability, price transparency, intake and eligibility gating, regulatory notes about compounded products, and plan features like bundled B12 and format switching. These are the most distinctive supported differences between Try Ageless and RxActivate.

Format availability and flexibility

Try Ageless offers three GLP-1 formats: compounded semaglutide injection, compounded tirzepatide injection, and needle-free tirzepatide oral drops. The drops are highlighted as an uncommon, needle-free option in the cash-pay market and Try Ageless allows switching between molecules or formats under one plan with no new consult fee. RxActivate advertises clinician-matched GLP-1 plans but the specific formats and whether oral drops are available are not disclosed before the eligibility gate.

Start RxActivate eligibility questionnaire

Price transparency and starting costs

Try Ageless publishes per-month starting prices on its landing page: semaglutide from $199/mo, tirzepatide from $249/mo, and tirzepatide oral drops from $159/mo when billed on a yearly plan. Try Ageless also states discount is already applied and a code SLIM50 stacks an extra $50 off every order. RxActivate does not display price or billing terms before users complete the intake flow and submit contact information. The comparison shows Try Ageless is transparent about starting costs while RxActivate gates pricing behind eligibility.

See Try Ageless pricing details

Intake, eligibility and state availability

RxActivate uses a two-minute eligibility questionnaire that collects goal, height, weight, target weight, timeline, medication history, sex assigned at birth, date of birth, and state. A synthetic test confirmed Alabama as serviceable and the flow displays likely eligibility but requires name, email and phone number before showing pricing. Try Ageless requires a prescription via telehealth and notes plans are state-licensed U.S. pharmacies and clinician-prescribed, but specific state availability is not enumerated in the supplied facts.

Compounding and regulatory notes

Both providers include regulatory qualifiers. Try Ageless dispenses compounded semaglutide and tirzepatide prepared by state-licensed 503A pharmacies and states that compounded medications are not FDA-approved or reviewed by FDA for safety, effectiveness or quality. RxActivate notes medication-specific approval status must be confirmed and that branded and compounded products are not interchangeable. These regulatory notes are preserved exactly.

Plan features and bundles

Try Ageless lists B12 bundled into every plan for energy support during weight loss, free discreet shipping, cancel anytime, and the ability to switch formats or molecules under one plan with no new consult fee. Try Ageless markets a discount already applied and the optional SLIM50 code. RxActivate highlights clinician-matched plans and state and medical safety screening but does not display membership, shipping, cancellation, or billing commitments before the contact-information gate.

Comparison table

Criteria Try Ageless RxActivate
Formats offered Semaglutide injection, tirzepatide injection, tirzepatide oral drops Clinician-matched GLP-1 plans; specific formats not disclosed before intake
Starting price shown Yes – drops from $159/mo, semaglutide from $199/mo, tirzepatide from $249/mo No – pricing gated behind eligibility and contact info
Pricing gate No, prices published and discounts noted Yes, requires questionnaire and contact information
Bundled features B12 included in every plan, free discreet shipping, switch formats under plan State and medical safety screening, clinician matching
Regulatory note Compounded medications not FDA-approved Medication approval status must be confirmed; compounded not interchangeable

How to decide between Try Ageless vs RxActivate

If you value visible starting prices, a choice of formats including a needle-free tirzepatide drop option, bundled B12, and an explicit discount structure, Try Ageless is the clearer option based on the supplied facts. If you prefer to be matched by a clinician and are prepared to complete a short intake before seeing pricing and terms, RxActivate fits that flow.

Begin RxActivate intake

Choose Try Ageless if

  • You want published starting prices and a low entry price: tirzepatide oral drops from $159/mo on a yearly plan.
  • You want three GLP-1 formats and the option to switch formats or molecules under one plan with no new consult fee.
  • You value bundled B12 and an advertised discount already applied plus an extra SLIM50 code for $50 off.

Choose RxActivate if

  • You prefer clinician matching and are willing to complete the eligibility questionnaire to learn pricing and availability.
  • You want state and medical-safety screening up front and to confirm medication suitability with a clinician before enrollment.

Compare Try Ageless plans now

This comparison used only the supplied provider facts. For Try Ageless vs RxActivate the primary differences are format transparency, published starting prices, eligibility gating, bundled features, and regulatory notes about compounded medications.

Ready to Compare Telehealth Providers?

Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.

Compare All Providers →

Related articles

Medical disclaimer: This page is for informational purposes only and is not medical advice. Always consult a licensed healthcare provider before starting any treatment. We may earn a commission from partner links on this page - see our advertising disclosure.